Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Morgan C. Frank | CEO & Chairman | 4 | -- | 1973 |
| Mr. Andrew Walko | President | 230k | -- | 1985 |
| Ms. Nanci Gilmore | Chief Commercial Officer | 297.2k | -- | 1972 |
| Mr. Peter Sorensen | Chief Financial Officer | -- | -- | 1993 |
| Mr. Peter Stegagno | Chief Operating Officer | 247.83k | -- | 1960 |
| Dr. Iulian Cioanta Ph.D. | Chief Science & Technology Officer | 233.68k | -- | 1963 |
| Mr. Timothy Wern | Executive Vice President of Sales - U.S. Wound | -- | -- | 1968 |
SANUWAVE Health, Inc. Common Stock
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 46
Description
SANUWAVE Health, Inc., a medical device company, focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures in the United States and internationally. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Corporate Governance
Upcoming Events
May 8, 2025 at 12:30 PM UTC - May 12, 2025 at 12:30 PM UTC
SANUWAVE Health, Inc. Common Stock Earnings Date